New study seeks genetic clues to rising colorectal cancer in young adults
NCT ID NCT02863107
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study investigates genetic factors that may increase the risk of developing colorectal cancer at a young age (18-50). Researchers will collect blood or saliva samples and review medical records from 818 participants, including patients and their family members. The goal is to find genetic markers that could help identify people at higher risk and improve early detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify people at higher risk for young-onset colorectal cancer, leading to earlier screening and prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly change patient care, and findings may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson League City
League City, Texas, 77573, United States
-
MD Anderson West Houston
Houston, Texas, 77079, United States
-
MD Anderson in Sugar Land
Sugar Land, Texas, 77478, United States
-
MD Anderson in The Woodlands
Conroe, Texas, 77384, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Rearranging the treatment timeline: could a new sequence of chemo and radiation spare rectal cancer patients from major surgery?
- Rectal cancer: could a 'Watch and Wait' strategy spare patients from major surgery?
- Blood test and CT combo may spare rectal cancer patients a second surgery
- Can a new drug ST316 shrink Hard-to-Treat tumors?